PRF Technologies logo
PRF Technologies
PRFX | NASDAQ
Chart Builder DCF Calculator
$0.69
-$0.09 (-11.83%)
At close: Nov 16, 2026, 4:00 PM ET
$0.75
+$0.06 (+8.70%)
After-hours: Nov 16, 2026, 4:43 PM ET

PRF Technologies Company Profile

Company profile explained

Company Profile

PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.

Key Executives

Name Position
Efraim Cohen-Arazi Interim CEO & Director
Eyal Broder Chief Financial Officer
Sigal Aviel Chief Operating Officer
Ehud Geller Executive Chairman
Rita Keynan Vice President of Pharmaceutical Operations

Latest SEC Filings

Date Type Title
Oct 23, 2026 6-K Filing
Sep 28, 2026 6-K Filing
Sep 24, 2026 SC 13D Filing
Sep 16, 2026 6-K Filing
Sep 09, 2026 6-K Filing
Sep 03, 2026 EFFECT Filing
Sep 03, 2026 POS AM Filing
Sep 03, 2026 6-K Filing
Jul 27, 2026 6-K Filing
Jul 21, 2026 6-K Filing
View All SEC Filings ➞
PRF Technologies
PRF Technologies logo
Country Israel
IPO Date Sep 1, 2020
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 7
CEO Efraim Cohen-Arazi

Contact Details

65 Yigal Alon Street Tel Aviv, TA 6744316 Israel

Stock Details

Ticker Symbol PRFX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001801834
CUSIP Number M77798201
ISIN Number IL0011651580
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.